Literature DB >> 34391631

Fatal disseminated Anncaliia algerae myositis mimicking polymyositis in an immunocompromised patient.

Fouzia Ziad1, Thomas Robertson2, Matthew R Watts3, Justin Copeland4, Graham Chiu5, David Wang6, Damien Stark7, Linda Graham8, Clinton Turner8, Richard Newbury9.   

Abstract

We report the first New Zealand case of Anncaliia algerae myositis in a 55-year-old man with a history of psoriatic arthritis, treated with long-term immunosuppressive therapy. He resided in the city of Rotorua, which is famous for geothermal hot springs. A vastus lateralis muscle biopsy was performed to investigate the cause of an unexplained myositis. Light microscopy demonstrated a necrotizing myositis with scattered clusters of ovoid spores within the myocyte cytoplasm resembling microsporidia. DNA analysis by PCR and electron microscopy confirmed microsporidial myositis with features characteristic of A. algerae. Immunosuppressive drugs were stopped and the patient was treated with cholestyramine wash and albendazole. The patient deteriorated with involvement of bulbar and respiratory muscles requiring intensive care and ventilation. He died 3 weeks after diagnosis. Post-mortem examination of skeletal muscle from tongue and intercostal muscles also revealed numerous organisms confirming disseminated disease.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anncaliia Algerae; Immunocompromised; Microsporidia; Myositis

Mesh:

Substances:

Year:  2021        PMID: 34391631     DOI: 10.1016/j.nmd.2021.06.007

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  2 in total

Review 1.  Current Therapy and Therapeutic Targets for Microsporidiosis.

Authors:  Junhong Wei; Zhihui Fei; Guoqing Pan; Louis M Weiss; Zeyang Zhou
Journal:  Front Microbiol       Date:  2022-03-09       Impact factor: 5.640

2.  Anncaliia algerae Microsporidiosis Diagnosed by Metagenomic Next-Generation Sequencing, China.

Authors:  Chen Liu; Qin Chen; Ping Fu; Yun-Ying Shi
Journal:  Emerg Infect Dis       Date:  2022-07       Impact factor: 16.126

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.